Low incidence of Helicobacter pylori infection in patients with duodenal ulcer and chronic liver disease

Scandinavian Journal of Gastroenterology

Volumn 36, Issue 5, 2001, Pages 479-484

  Shahin, W A ^a   Abdel Baset, E Z ^a   Nassar, A K ^a   Atta, M M ^a   Kabil, S M ^a   Murray, J A ^a  

^a MAYO CLINIC   (United States)

Author keywords

Cirrhosis; Gastritis; Nitric oxide; Peptic ulcer disease; Peroxynitrite

Indexed keywords

3 NITROTYROSINE; HISTAMINE H2 RECEPTOR ANTAGONIST; NITRIC OXIDE; OMEPRAZOLE; OXYGEN RADICAL;

ADULT; AGED; ARTICLE; BIOPSY TECHNIQUE; CHRONIC LIVER DISEASE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DUODENUM ULCER; FEMALE; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; HUMAN TISSUE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; STOMACH ANTRUM; STOMACH ULCER;

EID: 0035061979     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655201750153250     Document Type: Article

References (36)

1. Studies on peptic ulceration and portal hypertension in patients with schistosomiasis
2. Helicobacter pylori in cirrhotic patients with peptic ulcer disease: A prospective, case controlled study
3. Prevalence of duodenal ulcer in cirrhotic patients and its relation to Helicobacter pylori and portal hypertension
4. Effect of omeprazole on nocturnal intragastric pH in cirrhotics with inadequate antisecretory response to ranitidine
5. Activity of gastric mucosal nitric oxide synthase in portal hypertensive gastropathy
6. Long-term follow-up of duodenal ulcer patients
7. The natural course of peptic ulcer disease and its predictors
8. Randomised, double blind comparison of omeprazole and cimetidine in the treatment of symptomatic gastric ulcer
9. Double blind comparison of omeprazole (40 mg od) versus cimetidine (400 mg qd) in the treatment of symptomatic erosive reflux oesophagitis, assessed endoscopically, histologically and by 24 h pH monitoring
10. Omeprazole or ranitidine in long-term treatment of reflux esophagitis
11. Bismuth
12. Omeprazole and liver functions
13. Medical treatment of peptic ulcer disease
14. Omeprazole provides quicker symptom relief and duodenal ulcer healing than ranitidine
15. U.S. experience with omeprazole in duodenal ulcer. Multicenter double-blind comparative study with ranitidine
16. Omeprazole
17. Diagnostic tests for Helicobacter pylori (Hp) infection in cirrhotic and non-cirrhotic patients
18. Role of Helicobacter pylori in cirrhotic patients with peptic ulcer. A serological study
19. Colonization by Helicobacter pylori and its relationship to histological changes in the gastric mucosa in portal hypertension
20. Endoscopic and histologic appearance of the gastric mucosa in patients with portal hypertension
21. Histological staining methods for detection of gastric campylobacter like organisms (GCLOs): A comparative study
22. Helicobacter pylori infection density and gastric inflammation in duodenal ulcer and non-ulcer subjects
23. Gastroesophageal endoscopic features in cirrhosis. Observer variability, interassociations, and relationship to hepatic dysfunction
24. Natural history of congestive gastropathy in cirrhosis
25. Congestive gastropathy and Helicobacter pylori: An endoscopic and morphometric study
26. Peptic ulcer in cirrhotic patients: A short- and long-term study with antisecretory drugs
27. Double-blind trial of omeprazole and amoxicillin to cure Helicobacter priori infection in patients with duodenal ulcers
28. Evidence for in vivo peroxynitrite production in human chronic hepatitis
29. Helicobacter pylori from duodenal ulcer patients expresses inducible nitric oxide synthase immunoreactivity in vivo and in vitro
30. Production of reactive oxygen species by gastric cells in association with Helicobacter pylori
31. Helicobacter pylori induces apoptosis in gastric epithelial cells through inducible nitric oxide
32. Relationship between the mucosal production of reactive oxygen radicals and density of Helicobacter pylori in patients with duodenal ulcer
33. Helicobacter pylori-associated ammonia production enhances neutrophil-dependent gastric mucosal cell injury
34. Oxygen metabolism in blood of patients with gastric and duodenal ulcer disease
35. Superoxide dismutase activity in duodenal ulcer patients
36. Lipid peroxidation in patients with gastric and duodenal peptic ulcers